Sanofi India Limited — Board Meeting, 14-05-2025: Outcome of Board Meeting

Sanofi India has announced a board meeting approving the financial results for the quarter and half-year. Net sales grew 4%, led by strong traction in its diabetes portfolio, including the successful Soliqua® launch. Operating profits jumped 27% to ₹162 Cr, driven by tight cost controls and better efficiencies. The company stays committed to its ‘India for India’ strategy, boosting market reach and innovation. Earnings per share stood at ₹51.89 for continuing operations, highlighting solid financial discipline as Sanofi expands access to its innovative treatments.